The main market opportunities include enhancing pharmaceutical manufacturing quality through advanced cGMP training, reducing violations, and improving operational efficiency by adhering to FDA ...
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized supportWALTHAM, ...
9hon MSN
Bianca Censori debuts unexpected new look as guest critic at Columbia university architecture review
The Australian architecture stepped out in New York City with a refined and restrained aesthetic ...
Insilico Medicine announced the expansion of its MMAI Gym, a foundation-model training framework and platform for large-scale ...
OpenAI Has a New AI Model Built for Biology and Science ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress within its artificial ...
Opinion: As AI use becomes more frequent in the invention of new drugs, it’s important to determine how it affects who’s ...
OpenAI Foundation pledges $100 million to Alzheimer’s research, highlighting AI’s potential to accelerate diagnosis, drug ...
Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.
Ramakrishna Sesham, Senior Manager at Astellas Pharma, develops enterprise data governance frameworks that reduce FDA ...
A sit-down with Professor Eric Xing, the president of the UAE’s Mohamed bin Zayed University of Artificial Intelligence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results